Insider Insights
04.05.2022
UK second lowest across major health outcomes

The data is derived from the Organisation for Economic Co-operation and Development (OECD) Health St...

Read more
Insider Insights
04.05.2022
CNAM spending on medicines 11.1% in 2022

Spending by the main health insurance fund (Caisse nationale d’assurance maladie, CNAM) on medicin...

Read more
04.05.2022
PMA Insights: Week 18

A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...

Read more
Insider Insights
29.04.2022
EUCOPE anticipates OMP Regulation review

EUCOPE notes that “while these proposals don’t necessarily represent the final options included ...

Read more
Insider Insights
27.04.2022
Optimised NICE recommendations

According to the ABPI, over the last 20 years, 82% of technology appraisal recommendations have been...

Read more
Insider Insights
21.04.2022
Innovation and affordability of orphan drugs

The paper examines potential reforms to current policies and practices related to orphan drug develo...

Read more
Insider Insights
20.04.2022
Access to cancer drugs

According to the report, the financing of cancer drugs in Spain is “very high” with 90% of oncol...

Read more
Insider Insights
19.04.2022
Payment model to be launched for antibiotics

The UK looks set to become the first country in the world to use a subscription-style payment model ...

Read more
Insider Insights
11.04.2022
Streamline negotiation of price conditions

The amendment includes a number of articles which aims to “streamline the negotiation of the price...

Read more
Insider Insights
25.03.2022
UK-wide commitments for genomics initiatives

According to the Department of Health and Social Care (DHSC), the commitments will enable patients t...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.